ContextVision AB (publ) (OSL:CONTX)

Market Cap	255.93M -37.3%
Revenue (ttm)	115.15M -19.8%
Net Income	3.82M -83.4%
EPS	0.05 -83.2%
Shares Out	75.27M
PE Ratio	68.01
Forward PE	40.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	274,239
Average Volume	36,706
Open	3.310
Previous Close	3.400
Day's Range	3.050 - 3.400
52-Week Range	3.050 - 6.600
Beta	0.48
RSI	39.50
Earnings Date	Feb 19, 2026

About ContextVision AB

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1989
• Employees: 44
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2024, ContextVision AB's revenue was 130.84 million, a decrease of -1.33% compared to the previous year's 132.60 million. Earnings were 24.68 million, a decrease of -24.60%.

Financial numbers in SEK